Over-the-Counter Retail Naloxone Sales

Q: What type of study is this?

This is a Cross-Sectional Study study.

Bradley D. Stein; Rachel K. Landis; Rosanna Smart; Phoebe Rose Levine; Abigail Kessler; Mark Sorbero; Rosalie Liccardo Pacula

doi:10.1001/jamainternmed.2025.4590

September 15, 2025JAMA Internal Medicine

Over-the-Counter Retail Naloxone Sales

View Full Paper

Ask AI

Bookmark

Share

Key Points

Naloxone retail sales demonstrate significant trends in their first year, indicating an increased accessibility of this life-saving drug.
The analysis includes comparisons between over-the-counter sales, pharmacy-dispensed, and program-distributed naloxone, revealing important patterns.
Cross-sectional study employing data on naloxone sales trends over one year shows how availability may impact public health outcomes.
Findings may help inform future distribution strategies of naloxone as a response to opioid overdose crises.

Implication

This cross-sectional study explores naloxone retail sales trends, highlighting its relationship with pharmacy and program distributions.

Abstract

This cross-sectional study examines first-year over-the-counter naloxone sales trends independently and in association with pharmacy-dispensed and program-distributed naloxone.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Stein et al. (2025) studied this question.

synapsesocial.com/papers/68d44f8c31b076d99fa5734e https://doi.org/10.1001/jamainternmed.2025.4590

View Full Paper

Ask AI

Bookmark

Share

Over-the-Counter Retail Naloxone Sales

Key Points

Implication

Abstract

Discussion

Cite This Study

Over-the-Counter Retail Naloxone Sales

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading